PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE “TRANSPARENCY LAW”)

    NEXT STORY
    Novartis appoints John Tsai Head of Global Drug Development and Chief Medical Officer
    PREV STORY
    Novartis a réalisé une bonne performance au premier trimestre et agi pour devenir une entreprise plus centrée sur les médicaments
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    VBL Therapeutics to Report Fourth Quarter 2019 Financial Results on March 19

    author_avatar
    NASDAQ Market News

    Zafgen Reports Fourth Quarter and Full Year 2015 Financial Results

    BOSTON, March 09, 2016 (GLOBE NEWSWIRE) -- Zafgen (Nasdaq:ZFGN), a biopharmaceutical company dedicated to ...

    author_avatar
    NASDAQ Market News

    ChemoCentryx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights

    author_avatar
    NASDAQ Market News